Current position:Home >Product >
calcium (5Z)-5-[2-(4-methyl-2-sulfonatophenyl)hydrazinylidene]-6-oxo-5,6-dihydronaphthalene-2-sulfonate
calcium (5Z)-5-[2-(4-methyl-2-sulfonatophenyl)hydrazinylidene]-6-oxo-5,6-dihydronaphthalene-2-sulfonate(96293-51-5)
- Name: calcium (5Z)-5-[2-(4-methyl-2-sulfonatophenyl)hydrazinylidene]-6-oxo-5,6-dihydronaphthalene-2-sulfonate
- Synonyms:2-Naphthalenesulfonic acid,6-hydroxy-5-((4-methyl-2-sulfophenyl)azo)-,calcium salt (1:1);2-Naphthalenesulfonic acid,6-hydroxy-5-((4-methyl-2-sulfophenyl)azo)-,calcium salt (1:1) 7-Benzothiazolesulfonic acid,2-(4-((2-(cyanoimino)hexahydro-4,6-dioxo-5-pyrimidinyl)azo)phenyl)-6-methyl-,compd. with 2,2',2''-nitrilotris(ethanol) (1:1);2-Naphthalenesulfonic acid,6-hydroxy-5-(2-(4-methyl-2-sulfophenyl)diazenyl)-,calcium salt (1:1);
- Molecular Formula:C17H12CaN2O7S2
- Molecular Weight:460.4944
- CAS Registry Number:96293-51-5
- EINECS:
- Melting Point:
- Water Solubility:

Other Product
- 1888-94-4/2-CHLOROETHYL METHACRYLATE
- 7444-55-5/2-Amino-4-oxo-5-chloropentanoate
- 52259-61-7/7-HYDROXYMYOPORONE
- 109940-19-4/SULPHOSUCCINIMIDYL-6-(BIOTINAMIDO)HEXANOATE
- 2356-01-6/2,3,3,4,4,5,5,6,6-Nonafluoro-1-(2,2,2-trifluoroethoxy)-1-cyclohexene
- 184025-39-6/Spiro[5H,6H-5a,9a-(iminomethano)-1H-cyclopent[ f]indolizine-7(8H),3'(2'H)-pyrano[2,3-g]- indole]-2',5,10-trione,1',2,3,7',8a,9- hexahydro-6-hydroxy-7',7',8,8-tetramethyl-,(3'R,5aR,6S,8aS,9aS)-
- 119-47-1/2,2'-Methylenebis(6-tert-butyl-4-methylphenol)
- 1322-06-1/Phenol, pentyl-
- 143212-80-0/ethyl [(7-amino[1,2,4]triazolo[1,5-c]pyrimidin-5-yl)sulfanyl]acetate
- 500-00-5/p-menth-3-ene
- 90459-64-6/Octadecanoic acid, reaction products with N,N-dimethyl-1,3-propanediamine
- 35231-92-6/naphthalen-2-yl 2,2,4,4-tetramethylpentanoate
- 66757-01-5/N,N-Bis(4-(9-acridinylamino)phenyl)-1,5-pentanedisulfonamide dihydrochloride hydrate
- 56312-78-8/Phosphonodiselenous acid
- 68920-36-5/Fatty acids, tall-oil, polymers with glycerol, pentaerythritol, polyethylene glycol and trimellitic anhydride
- 62482-30-8/ETHYL 6-BROMO-2-METHYLQUINOLINE-4-CARBOXYLATE
- 122577-78-0/Pregnan-20-one,11-(acetyloxy)-12-(benzoyloxy)-3-[(O-2,6-dideoxy-3-O-methyl-a-L-ribo-hexopyranosyl-(1®4)-O-2,6-dideoxy-3-O-methyl-b-D-arabino-hexopyranosyl-(1®4)-O-2,6-dideoxy-b-D-ribo-hexopyranosyl-(1®4)-2,6-dideoxy-b-D-ribo-hexopyranosyl)oxy]-14-hydroxy-,(3b,5a,11a,12b,14b)- (9CI)
- 5892-10-4/Bismuth subcarbonate
- 74137-66-9/ERGOCRYPTININE METHANESULFONATE
- 96293-51-5/calcium (5Z)-5-[2-(4-methyl-2-sulfonatophenyl)hydrazinylidene]-6-oxo-5,6-dihydronaphthalene-2-sulfonate
- 156848-67-8/peyssonol A
- 97743-93-6/Pregn-5-ene-3,11,12,14,20-pentol,12,20- dibenzoate,(3â,11R,12â,14â,20R)-
- 13755-32-3/PLATINUM BARIUM CYANIDE
- 101652-05-5/3-(6,7-dichloro-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-N-ethyl-N-(2-hydroxyethyl)propan-1-aminium hydrogen sulfate
- 20432-64-8/6,7,8,9,10,11-hexahydro-N,N-dimethyl-5H-cyclooct[b]indole-5-propylamine monohydrochloride
- 2484-16-4/6,8-dimethyl-7H-benzo[7]annulen-7-one
- 41942-94-3/2-hydroxy-4-(hydroxymethyl)phenyl 6-O-benzoyl-beta-D-glucopyranoside
- 1519-45-5/ETHYLENEBIS(TRIPHENYLPHOSPHONIUM BROMIDE)
- 459-72-3/Ethyl fluoroacetate
- 37221-79-7/Vasoactive Intestinal Peptide